A Complete Pipeline for Isolating and Sequencing MicroRNAs, and Analyzing Them Using Open Source Tools
August 21st, 2019
7K views
Here, we describe a step-by-step strategy for isolating small RNAs, enriching for microRNAs, and preparing samples for high-throughput sequencing. We then describe how to process sequence reads and align them to microRNAs, using open source tools.
μ
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a detailed protocol for isolating small RNAs and enriching microRNAs for high-throughput sequencing. It also outlines the processing of sequence reads and alignment to microRNAs using open-source bioinformatics tools.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Bioinformatics
Background
- MicroRNAs play a crucial role in gene regulation.
- High-throughput sequencing provides insights into disease mechanisms.
- Accurate quantification of small RNAs is essential for gene therapy.
- Protocols must ensure RNase-free environments to prevent RNA degradation.
Purpose of Study
- To develop a reproducible protocol for small RNA sequencing.
- To analyze normalized reads using open-source tools.
- To enhance the understanding of microRNA processing and its implications in diseases.
Methods Used
- Isolation of small RNAs through gel purification.
- Preparation of samples for high-throughput sequencing.
- Use of three prime adaptor ligation for RNA.
- Bioinformatics analysis of sequencing data.
Main Results
- The protocol effectively collects microRNAs.
- Bioinformatics tools can be applied universally to microRNA data.
- Visual aids for gel cutting enhance protocol clarity.
- Insights into microRNA roles in gene therapy are highlighted.
Conclusions
- The developed protocol is defined and reproducible.
- It provides a reliable method for analyzing small RNAs.
- Future applications can lead to advancements in understanding disease mechanisms.
Frequently Asked Questions
What are small RNAs?
Small RNAs are short, non-coding RNA molecules that play critical roles in regulating gene expression.
Why is RNase-free environment important?
An RNase-free environment prevents degradation of RNA, ensuring the integrity of the samples.
What tools are used for bioinformatics analysis?
Open-source bioinformatics tools are utilized for processing and analyzing sequencing data.
How does gel purification work?
Gel purification separates RNA molecules based on size, allowing for the selective collection of microRNAs.
What insights can high-throughput sequencing provide?
It can reveal information about disease mechanisms and the processing of microRNAs.
What is three prime adaptor ligation?
It is a method used to attach a specific linker to the RNA, facilitating sequencing.
Executive Industry Relevance
Accurate microRNA quantification enables target validation and biomarker discovery in therapeutic development. This pipeline supports mechanistic de-risking by linking expression changes to disease mechanisms and gene therapy outcomes. It provides predictive confidence for prioritizing RNA-based interventions in preclinical portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of microRNA-mediated therapeutic hypotheses in disease models.
- Operational Value: Provides reproducible isolation of functional small RNAs for target pathway clarification.
- Scientific Value: Supports biological de-risking through quantification of microRNA alterations in disease states.
Screening & Assay Development
- Scientific Value: Generates quantitative microRNA expression data for assay standardization and reproducibility.
- Operational Value: Delivers normalized read counts enabling reliable compound screening and hit validation.
- Scientific Value: Facilitates preparation of validated biological systems for downstream biomarker screening workflows.
Translational & Preclinical Research
- Scientific Value: Connects microRNA expression changes to disease relevance and therapeutic response in preclinical models.
- Operational Value: Enables continuity from discovery through preclinical validation via consistent bioinformatic analysis.
- Strategic Value: Supports risk-adjusted advancement decisions by identifying dysregulated microRNA sets in cancer and other diseases.
Pipeline & Workflow Integration
The method integrates small RNA isolation with open-source sequencing analysis to support discovery-to-preclinical workflows.
- Discovery Biology: Supports hypothesis testing and pathway clarification through accurate microRNA quantification from tissue extracts.
- Screening: Enables assay readiness via gel-purified small RNA libraries compatible with high-throughput sequencing.
- Analytics: Provides normalized read counts and differential expression metrics for cross-condition comparison and target prioritization.
- Translational Research: Links microRNA processing insights to disease mechanism understanding in cancer and gene therapy contexts.
- Enterprise Reuse: Establishes a reusable protocol for small RNA analysis applicable across diverse sample collection methods.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through accurate microRNA quantification and differential expression analysis.
- Operational Value: Standardization and reproducibility via RNase-free gel purification and open-source bioinformatics tools.
- Strategic Value: Improved go/no-go decisions by linking microRNA profiles to disease mechanisms and therapeutic outcomes.
- Portfolio Impact: Risk-adjusted prioritization of RNA-based therapeutics based on validated microRNA biomarker signatures.
Implementation Considerations
- Requires expertise in molecular biology and RNA handling to maintain sample integrity.
- Dependent on electrophoresis and gel extraction equipment for size-specific microRNA isolation.
- Necessitates cross-team standardization of bioinformatic pipelines for consistent microRNA alignment and quantification.
- Adaptation considerations include varying input tissue types and RNA quality affecting gel-based recovery efficiency.
- Practical limitations include reliance on precise gel cutting under UV light to recover correct microRNA size fractions.
Biopharma FAQs
Why does gel purification matter for microRNA target validation?
Gel purification enables accurate recovery of microRNAs by size, which is essential for reliable quantification in target validation studies. This step ensures that only the correct small RNA fractions are carried forward for sequencing, reducing contamination and improving data integrity. Proper gel cutting supports reproducible isolation of functional microRNAs for downstream biomarker and therapeutic target assessment.
How does three prime adaptor ligation support discovery pipeline workflows?
Three prime adaptor ligation prepares microRNAs for high-throughput sequencing by attaching linkers compatible with downstream amplification and library preparation. This step is critical for converting purified small RNAs into sequencable molecules, enabling consistent input into the sequencing workflow. It allows the bioinformatics analysis to be applied regardless of upstream isolation method, supporting workflow flexibility in discovery pipelines.
What quantitative measurements enable microRNA differential expression analysis?
Normalized read counts obtained after alignment to microRNA hairpins enable quantification and comparison of microRNA expression across samples. These measurements allow users to calculate differential expression and identify significantly altered microRNAs in disease states. The protocol demonstrates strong concordance between replicates, supporting reliable detection of expression changes for target prioritization.
Why do replication requirements matter for cross-functional collaboration in microRNA studies?
Replication requirements ensure that microRNA read counts show strong concordance across samples, which is critical for building confidence in expression data shared between biology and bioinformatics teams. Consistent results across replicates support trust in the data when used for target validation or biomarker decisions. This reproducibility enables cross-functional alignment on dysregulated microRNA sets in disease models.
What statistical analysis capabilities are required before implementing microRNA sequencing data in target selection?
Users must be able to align sequencing reads to microRNA hairpins, quantify normalized read counts, and calculate differential expression to assess target relevance. These capabilities enable identification of microRNAs with significant expression changes in disease conditions, supporting mechanistic de-risking. The protocol shows that open-source tools can perform this analysis universally, allowing teams to prioritize targets based on robust statistical outputs.
